pharmacogenomics
The study of how an individual's genes affect their response to drugs, enabling personalized dosing and avoidance of adverse reactions
As defined in Eric Topol on the Creative Destruction of Medicine
Where it comes up · 3
- Investing in the Future of Healthcare1 claim
- Eric Topol on the Creative Destruction of Medicine1 claim
- Eric Topol on the Power of Patients in a Digital World1 claim
Most important claims · 3 of 3Search all claims for “pharmacogenomics” →
- Within the speaker's lifetime, doctors may use blood samples and gene analysis to prescribe a drug matched to the patient, building on oncology work by Flatiron Health showing that some cancer drugs work better for specific groups.Investing in the Future of Healthcare
- A $99 23andMe saliva scan of common genome variants, while limited, reveals roughly 25-30 major drug interactions with strong supporting data—such as personalized Warfarin dosing where one person needs only 2mg versus the average 5-7mg—making it a bargain even though it captures only hundreds of thousands of variants rather than the full 6-billion-letter genome.Eric Topol on the Creative Destruction of Medicine
- 23andMe collided with the FDA and was shut down partly because it launched an aggressive multi-million-dollar marketing campaign while being unresponsive to FDA correspondence, but its $99 service offering pharmacogenomic information on ~30 commonly used drugs was a genuine bargain, and direct-to-consumer genomics is acceptable as long as the data and interpretation are accurate and validated.Eric Topol on the Power of Patients in a Digital World